<DOC>
	<DOCNO>NCT01073579</DOCNO>
	<brief_summary>The purpose study create patient registry collect analyze information subject treat Sabril prescribers Sabril .</brief_summary>
	<brief_title>Sabril Patient Registry</brief_title>
	<detailed_description>This prospective registry part overall Risk Evaluation Mitigation Strategy ( REMS ) require Sabril United States Food Drug Administration ( FDA ) . All physician prescribe Sabril patient take Sabril enrol H. Lundbeck A/S-sponsored program call `` SHARE '' ( Support , Help Resources Epilepsy ) , data collect entered SHARE database form basis patient registry . Prior prescription fill one specialty pharmacy , prescribe physician patient must enrol SHARE . A call center ( SHARE Call Center ) act hub network select specialty pharmacy . Participation SHARE patient registry mandatory . Information regard prescriber specialty location , patient demographic disease characteristic collect SHARE enter database . Patients assign unique patient identifier upon entry registry , data related patient associate identifier . Early therapy ( within 2-4 week Infantile Spasms patient 3 month adult refractory Complex Partial Seizures patient ) , mandatory benefit/risk assessment occur . If benefit Sabril therapy exceed risk vision loss , prescribe physician complete submit appropriate SHARE form patient continue maintenance therapy phase treatment . The outcome benefit/risk assessment enter database . Regular assessment vision require Sabril therapy contribute information relate ongoing benefit/risk assessment . The required assessment occur baseline , every 3 month therapy , 3-6 month stop Sabril . The visual assessment result record submit use appropriate SHARE form , data enter database . A copy visual field include . Patients participate registry long receive Sabril therapy . Patients discontinue treatment Sabril , treat late time treat single patient registry .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Spasm</mesh_term>
	<mesh_term>Spasms , Infantile</mesh_term>
	<mesh_term>Vigabatrin</mesh_term>
	<criteria>All patient U.S. prescribe Sabril must participate patient registry order receive Sabril .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cryptogenic Infantile Spasms</keyword>
	<keyword>Cryptogenic West Syndrome</keyword>
	<keyword>Hypsarrhythmia</keyword>
	<keyword>Infantile Spasms</keyword>
	<keyword>Symptomatic Infantile Spasms</keyword>
	<keyword>Symptomatic West Syndrome</keyword>
	<keyword>West Syndrome</keyword>
	<keyword>Refractory Complex Partial Seizures</keyword>
	<keyword>Complex Partial Epilepsy</keyword>
	<keyword>Complex Partial Seizure Disorder</keyword>
	<keyword>Cryptogenic Partial Complex Epilepsy</keyword>
	<keyword>Disorder , Complex Partial Seizures</keyword>
	<keyword>Epilepsy , Cryptogenic , Partial Complex</keyword>
	<keyword>Epilepsy , Psychic Equivalent</keyword>
	<keyword>Epilepsy , Psychomotor</keyword>
	<keyword>Epilepsy , Symptomatic , Partial Complex</keyword>
	<keyword>Partial Complex Epilepsy , Cryptogenic</keyword>
	<keyword>Partial Complex Epilepsy , Symptomatic</keyword>
	<keyword>Seizure Disorder , Complex Partial</keyword>
	<keyword>Symptomatic Partial Complex Epilepsy</keyword>
</DOC>